|
Jeff Kleck is the CEO of Attainia, a leading SaaS (Software as a Service) provider to the healthcare market, focusing on solutions to manage healthcare's booming capital equipment segment. Prior to Attainia, Kleck co-founded Neoforma (NASDAQ: NEOF), where he served as chairman and CEO until July 1999, and is credited as one of the founders of business-to-business eCommerce. Neoforma's public debut became the 16th highest first day gainer in the history of IPOs on the NASDAQ. Prior to Neoforma, Kleck spent six years as senior engineer and marketing product manager at Varian Associates, a premier medical equipment manufacturer. Prior to his position at Varian, Kleck spent several years supervising health related programs at UCLA and Texas A&M. Kleck left Texas to join UCLA's prestigious Neutron Therapy Facility, working with the National Cancer Institute on nuclear radiation technology to diagnose and treat cancer. His work attracted the attention of the Los Alamos National Laboratory, where he became a visiting scientist and holds a patent for advanced radiation detection technology. Kleck is considered an international authority in the application of technology and software in healthcare. Jeff Kleck received a BS and an MS from Texas A&M University in Nuclear Engineering. He holds a PhD in biomedical physics from UCLA and is a member of the faculty of the UCLA School of Medicine. In addition, Kleck received an MS from Stanford University in Engineering Management while working at Varian. | 